Literature DB >> 11722031

Ross operation for active culture-positive aortic valve endocarditis with extensive paravalvular involvement.

A Prat1, J I Saez de Ibarra, A Vincentelli, C Decoene, O H Fabre, B Jegou, C Savoye.   

Abstract

BACKGROUND: We evaluated the midterm results of the Ross operation in active advanced endocarditis.
METHODS: Between June 1994 and June 2000 a pulmonary autograft aortic root replacement was performed in 11 consecutive patients who had urgent or emergent procedures for active endocarditis with extensive involvement of the aortic root (10 native, 1 prosthetic). Patients ranged in age from 26 to 45 years (median, 33 years). Indications for operation were uncontrolled infection (n = 5), hemodynamic deterioration (n = 3), or both (n = 3). Four patients were in the New York Heart Association class III, 6 in class IV, and 1 was operated on while in cardiogenic shock. Four patients (36%) suffered an embolic cerebrovascular accident preoperatively. The endocarditis affected the mitral valve in 2 patients and the tricuspid valve in 1 patient.
RESULTS: There was no early or late death. Recurrent endocarditis was not detected in any of the patients during the follow-up period ranging up to 72 months (median, 40 months).
CONCLUSIONS: The autograft may well be the best substitute for aortic root reconstruction in advanced endocarditis.

Entities:  

Mesh:

Year:  2001        PMID: 11722031     DOI: 10.1016/s0003-4975(01)03020-x

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  2 in total

1.  Prosthetic valve endocarditis with extensive aortic root abscess: full aortic root reconstruction with stentless bioprosthesis, xenopericardium and mitral valve replacement.

Authors:  Keiichi Fujiwara; Hiroki Hayashi; Shuji Yamamoto; Hiroyoshi Komai; Yoshitaka Okamura
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2003-12

Review 2.  Surgical treatment for aortic periannular abscess/pseudoaneurysm caused by infective endocarditis.

Authors:  Kenji Okada; Yutaka Okita
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-11-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.